Top

Editorial Board

Editor-in-Chief

Editorial Board Members

  • Professor, Fred Wyszkowski Cancer Research Laboratory, Technion - Israel Institute of Technology, Haifa, Israel
  • President of the Oncoclinical Institute and Director of the Oncoclinica Group, Rio de Janeiro, Brazil
  • Professor, Department of Biomedical Sciences, Faculty of Medicine, University of Namur, Namur, Belgium
  • Associate Professor, Lab Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy.
  • Professor, Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
  • Cancer Biology Laboratory, Lutheran University of Brazil, Canoas, Brazil
  • Professor, Clinical Pharmacy Group, Department of Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany
  • Department of Rheumatology, Amsterdam Rheumatology and immunology Center (ARC), Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands
  • Division of Medical Oncology, University of Basel, Basel, Switzerland
  • Institute of Pharmacy, University of Bonn, Bonn, Germany
  • Professor, Faculty of Health Sciences, University of Macau, Macau, China
  • Professor, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA
  • Professor, School of Biosciences, University of Kent, Canterbury, UK.
  • Division of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
  • Department of Health Sciences, University of Florence, Florence, Italy
  • Molecular Pharmacology, School of Pharmaceutical Sciences (EPGL), University of Geneva, Geneva, Switzerland
  • Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy
  • Professor, School of Pharmacy, University of Huddersfield, Huddersfield, UK
  • Professor, Department of Genetics, Physical Anthropology and Animal Physiology (School of Medicine) of the University of the Basque Country (UPV/EHU), Basque Country, Spain
  • Nova Medical School (NMS), Universidade Nova de Lisboa/Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal
  • Professor, Division of Pharmaceutics & Pharmaceutical Chemistry College of Pharmacy, The Ohio State University, Columbus, OH, USA
  • Professor, Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité – Universitätsmedizin und Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany
  • Executive Medical Director, Global Oncology and Hematology, Syneos Health. President, Ares Pharmaceuticals, White Bear Lake, MN, USA
  • Professor, Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan
  • Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA
  • Professor, Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan
  • Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy